RxDoctor Payments Data

Kaitlyn Chittick-Myers

Nurse Practitioner · Wabash, INNPI 1790301257

Payments from drug & device makers

$5,027in general payments, 2019–2025

Across 330 payments — averaging $15.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$898
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$698
  • Takeda Pharmaceuticals U.S.A., Inc.$678
  • Lundbeck LLC$672
  • Alkermes, Inc.$461
  • Axsome Therapeutics, Inc.$400
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$4,88397%
  • Education$1443%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,027 in reported general payments places this provider in the 90th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole14$38,843
RexultiBrexpiprazole21$34,572
TrintellixVortioxetine Hydrobromide56$30,144
VivitrolNaltrexone Microspheres11$19,828
AuvelityDextromethorphan Hbr/Bupropion20$17,688
Aripiprazole37$4,343
Asenapine Maleate18$3,518
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl49$3,306
Quetiapine Fumarate ErQuetiapine Fumarate39$1,188
Buspirone Hcl41$727
Duloxetine Hcl11$721
Oxcarbazepine25$573
Trazodone Hcl47$573
Hydroxyzine Pamoate13$556
Hydroxyzine Hcl32$476

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$898$73,41535 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$678$30,14456 claims
Alkermes, Inc.Vivitrol$461$19,82811 claims
Axsome Therapeutics, Inc.Auvelity$400$17,68820 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Wabash

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →